Prednisolone retention in integrated liposomes by chemical approach and pharmaceutical approach

Mugen Teshima, Shigeru Kawakami, Koyo Nishida, Junzo Nakamura, Toshiyuki Sakaeda, Hideyuki Terazono, Takashi Kitahara, Mikiro Nakashima, Hitoshi Sasaki

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The purpose of this study is to demonstrate a stable retention of prednisolone (PLS) in the unique liposomes integrated by lipophilic derivative approach and PEGylation approach. Palmitoyl prednisolone (Pal-PLS) was newly synthesized and used as a lipophilic derivative. The liposomes were composed of egg phosphatidylcholine (EggPC)/cholesterol (Chol) and L-α- distearoylphosphatidylcholine (DSPC)/Chol with or without L-α- distearoylphosphatidylethanolamine-polyethylene glycol 2000 (DSPE-PEG 2000) or -PEG 5000 (DSPE-PEG 5000). The retentions of PLS and Pal-PLS in the various liposomes were examined by ultrafiltration and gel filtration. Although PLS showed high trapping efficiency by all liposomes after ultrafiltration, low incorporation efficiency was observed in gel filtration. It indicates that PLS was released from the liposomes by a dilution with elution medium in gel filtration. Pal-PLS showed high incorporation into all liposomes after both ultrafiltration and gel filtration. The high incorporation of Pal-PLS into EggPC/Chol liposomes, however, was reduced by incubation with rat plasma in gel filtration. The reducing effect of rat plasma on drug incorporation into liposomes was inhibited by using DSPC and DSPE-PEGs. Thus, we systemically examined the drug retention in various liposomes and demonstrated the high retention of PLS in the liposomes integrated by lipophilic derivative approach and pharmaceutical approach using special lipids.

Original languageEnglish
Pages (from-to)211-218
Number of pages8
JournalJournal of Controlled Release
Volume97
Issue number2
DOIs
Publication statusPublished - 2004 Jun 18
Externally publishedYes

Fingerprint

Prednisolone
Liposomes
Pharmaceutical Preparations
Gel Chromatography
Ultrafiltration
Cholesterol
Phosphatidylcholines
Ovum
palmitoyl prednisolone
Lipids

Keywords

  • Drug delivery system
  • Lipophilic derivative
  • Liposomes
  • Polyethylene glycol
  • Prednisolone

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Teshima, M., Kawakami, S., Nishida, K., Nakamura, J., Sakaeda, T., Terazono, H., ... Sasaki, H. (2004). Prednisolone retention in integrated liposomes by chemical approach and pharmaceutical approach. Journal of Controlled Release, 97(2), 211-218. https://doi.org/10.1016/j.jconrel.2004.03.011

Prednisolone retention in integrated liposomes by chemical approach and pharmaceutical approach. / Teshima, Mugen; Kawakami, Shigeru; Nishida, Koyo; Nakamura, Junzo; Sakaeda, Toshiyuki; Terazono, Hideyuki; Kitahara, Takashi; Nakashima, Mikiro; Sasaki, Hitoshi.

In: Journal of Controlled Release, Vol. 97, No. 2, 18.06.2004, p. 211-218.

Research output: Contribution to journalArticle

Teshima, M, Kawakami, S, Nishida, K, Nakamura, J, Sakaeda, T, Terazono, H, Kitahara, T, Nakashima, M & Sasaki, H 2004, 'Prednisolone retention in integrated liposomes by chemical approach and pharmaceutical approach', Journal of Controlled Release, vol. 97, no. 2, pp. 211-218. https://doi.org/10.1016/j.jconrel.2004.03.011
Teshima, Mugen ; Kawakami, Shigeru ; Nishida, Koyo ; Nakamura, Junzo ; Sakaeda, Toshiyuki ; Terazono, Hideyuki ; Kitahara, Takashi ; Nakashima, Mikiro ; Sasaki, Hitoshi. / Prednisolone retention in integrated liposomes by chemical approach and pharmaceutical approach. In: Journal of Controlled Release. 2004 ; Vol. 97, No. 2. pp. 211-218.
@article{ea39c544b9104d4da3705cd4d0ae47d6,
title = "Prednisolone retention in integrated liposomes by chemical approach and pharmaceutical approach",
abstract = "The purpose of this study is to demonstrate a stable retention of prednisolone (PLS) in the unique liposomes integrated by lipophilic derivative approach and PEGylation approach. Palmitoyl prednisolone (Pal-PLS) was newly synthesized and used as a lipophilic derivative. The liposomes were composed of egg phosphatidylcholine (EggPC)/cholesterol (Chol) and L-α- distearoylphosphatidylcholine (DSPC)/Chol with or without L-α- distearoylphosphatidylethanolamine-polyethylene glycol 2000 (DSPE-PEG 2000) or -PEG 5000 (DSPE-PEG 5000). The retentions of PLS and Pal-PLS in the various liposomes were examined by ultrafiltration and gel filtration. Although PLS showed high trapping efficiency by all liposomes after ultrafiltration, low incorporation efficiency was observed in gel filtration. It indicates that PLS was released from the liposomes by a dilution with elution medium in gel filtration. Pal-PLS showed high incorporation into all liposomes after both ultrafiltration and gel filtration. The high incorporation of Pal-PLS into EggPC/Chol liposomes, however, was reduced by incubation with rat plasma in gel filtration. The reducing effect of rat plasma on drug incorporation into liposomes was inhibited by using DSPC and DSPE-PEGs. Thus, we systemically examined the drug retention in various liposomes and demonstrated the high retention of PLS in the liposomes integrated by lipophilic derivative approach and pharmaceutical approach using special lipids.",
keywords = "Drug delivery system, Lipophilic derivative, Liposomes, Polyethylene glycol, Prednisolone",
author = "Mugen Teshima and Shigeru Kawakami and Koyo Nishida and Junzo Nakamura and Toshiyuki Sakaeda and Hideyuki Terazono and Takashi Kitahara and Mikiro Nakashima and Hitoshi Sasaki",
year = "2004",
month = "6",
day = "18",
doi = "10.1016/j.jconrel.2004.03.011",
language = "English",
volume = "97",
pages = "211--218",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Prednisolone retention in integrated liposomes by chemical approach and pharmaceutical approach

AU - Teshima, Mugen

AU - Kawakami, Shigeru

AU - Nishida, Koyo

AU - Nakamura, Junzo

AU - Sakaeda, Toshiyuki

AU - Terazono, Hideyuki

AU - Kitahara, Takashi

AU - Nakashima, Mikiro

AU - Sasaki, Hitoshi

PY - 2004/6/18

Y1 - 2004/6/18

N2 - The purpose of this study is to demonstrate a stable retention of prednisolone (PLS) in the unique liposomes integrated by lipophilic derivative approach and PEGylation approach. Palmitoyl prednisolone (Pal-PLS) was newly synthesized and used as a lipophilic derivative. The liposomes were composed of egg phosphatidylcholine (EggPC)/cholesterol (Chol) and L-α- distearoylphosphatidylcholine (DSPC)/Chol with or without L-α- distearoylphosphatidylethanolamine-polyethylene glycol 2000 (DSPE-PEG 2000) or -PEG 5000 (DSPE-PEG 5000). The retentions of PLS and Pal-PLS in the various liposomes were examined by ultrafiltration and gel filtration. Although PLS showed high trapping efficiency by all liposomes after ultrafiltration, low incorporation efficiency was observed in gel filtration. It indicates that PLS was released from the liposomes by a dilution with elution medium in gel filtration. Pal-PLS showed high incorporation into all liposomes after both ultrafiltration and gel filtration. The high incorporation of Pal-PLS into EggPC/Chol liposomes, however, was reduced by incubation with rat plasma in gel filtration. The reducing effect of rat plasma on drug incorporation into liposomes was inhibited by using DSPC and DSPE-PEGs. Thus, we systemically examined the drug retention in various liposomes and demonstrated the high retention of PLS in the liposomes integrated by lipophilic derivative approach and pharmaceutical approach using special lipids.

AB - The purpose of this study is to demonstrate a stable retention of prednisolone (PLS) in the unique liposomes integrated by lipophilic derivative approach and PEGylation approach. Palmitoyl prednisolone (Pal-PLS) was newly synthesized and used as a lipophilic derivative. The liposomes were composed of egg phosphatidylcholine (EggPC)/cholesterol (Chol) and L-α- distearoylphosphatidylcholine (DSPC)/Chol with or without L-α- distearoylphosphatidylethanolamine-polyethylene glycol 2000 (DSPE-PEG 2000) or -PEG 5000 (DSPE-PEG 5000). The retentions of PLS and Pal-PLS in the various liposomes were examined by ultrafiltration and gel filtration. Although PLS showed high trapping efficiency by all liposomes after ultrafiltration, low incorporation efficiency was observed in gel filtration. It indicates that PLS was released from the liposomes by a dilution with elution medium in gel filtration. Pal-PLS showed high incorporation into all liposomes after both ultrafiltration and gel filtration. The high incorporation of Pal-PLS into EggPC/Chol liposomes, however, was reduced by incubation with rat plasma in gel filtration. The reducing effect of rat plasma on drug incorporation into liposomes was inhibited by using DSPC and DSPE-PEGs. Thus, we systemically examined the drug retention in various liposomes and demonstrated the high retention of PLS in the liposomes integrated by lipophilic derivative approach and pharmaceutical approach using special lipids.

KW - Drug delivery system

KW - Lipophilic derivative

KW - Liposomes

KW - Polyethylene glycol

KW - Prednisolone

UR - http://www.scopus.com/inward/record.url?scp=2942583952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942583952&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2004.03.011

DO - 10.1016/j.jconrel.2004.03.011

M3 - Article

VL - 97

SP - 211

EP - 218

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 2

ER -